Patent · US Active

Somatic cell reprogramming

US10106772B2 · kind B2 · utility

2Cited by
11References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 11, 2013
Grant dateOct 23, 2018
Priority date
Expiry dateMar 11, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2799/027
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to methods for reprogramming a somatic cell to pluripotency by administering into the somatic cell at least one or a plurality of potency-determining factors. The invention also relates to pluripotent cell populations obtained using a reprogramming method.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.